Post AASLD CME

Virtual Program

Thursday, December 3

6:00-9:00 p.m.

Registration is free!

Program Overview

The goal of the CME program is to learn more about current trends, management techniques, recent innovations, and research to treat a full range of liver conditions, including Fatty Liver/NASH, Hepatocellular Carcinoma, Cholestatic Diseases, and Liver Transplantation. The American Association for the Study of Liver Diseases (AASLD) is the leading organization of scientists and healthcare professionals committed to preventing and curing liver disease. The AASLD fosters research that leads to improved treatment options for millions of liver disease patients. They advance the science and practice of hepatology through educational conferences, training programs, professional publications, and partnerships with government agencies and sister societies. Each November, the AASLD holds the Annual Liver Meeting to provide access and education to groundbreaking science, the exchange of ideas with leading clinicians and researchers, and network with peers.

 

Who Should Attend?

This course is designed for providers in hepatology, gastroenterology, and abdominal and general surgery, referring primary care physicians, and other health care professionals with an interest in the treatment and latest research for liver disease.

Learning Objectives

At course completion, attendees should be able to:

  • Identify advancements in non-alcoholic and alcoholic liver disease treatments, with attention to liver diseases such as NAFLD, cholestatic diseases, hepatocellular carcinoma, and viral hepatitis.

  • Address barriers to liver transplantation and living-donor liver transplant, leading to enhanced patient care.

  • Foster the development of multidisciplinary and interactive models to treat liver diseases.

  • Partner with other regional academic liver programs and regional nonprofit collaborators to educate the regional medical community about liver disease advancements.

REGISTRATION IS FREE FOR PROVIDERS, STUDENTS, PATIENTS AND CAREGIVERS

CME Accreditation and Designation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint provider ship of Excela Health and the Community Liver Alliance. Excela Health is accredited by the ACCME to provide continuing medical education for physicians.

 

Excela Health designates this live activity for a maximum of 3.0 AMA PRA Category Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Other health care professionals are awarded 0.3 continuing education units (CEU’s) which are equal to 3 contact hours.

Faculty Disclosure

All individuals in a position to control the content of this education activity including members of the planning committee, speakers, presenters, authors, and/or content reviewers have disclosed all relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients.

 

The following relevant financial relationships were disclosed

Michael Babich, MD - AstraZeneca Research Grant, Synthes Consultant, Merck Speaker’s Bureau.

Acknowledgement of Commercial Support

We gratefully acknowledge Virtual Exhibitors support from the following to support this activity:

 

 

 

*Industry partners must have an exhibit to attend the program. You can purchase your exhibit registration by contacting Molly Sweet at molly@communityliveralliance.org.

Rx.png
bms-logo.png
800px-AbbVie_logo.svg.png
1200px-Eisai_logo.svg.png
120px-Logo_Bayer.svg.png